New implementation arrangements have been put in place for the TB programs funded through Nigeria’s new TB and TB/HIV grants.
The Global Fund seeks the right balance between risk mitigation and grant implementation in Mali malaria grant
When it recommended a Mali malaria grant for approval recently, the Global Fund’s Grant Approvals Committee (GAC) acknowledged that there are implementation challenges associated with this grant and said that it welcomed the Secretariat’s plans “to identify bottlenecks, and holistically review and harmonize the controls in place with the aim of balancing risk mitigation and effective grant implementation.”
Among the grants approved by the Global Fund Board on 21 December 2018 (see GFO article) were three multi-country grants. Two of the grants were for Eastern Europe and Central Asia (EECA); the third was for West and Central Africa. (See table.)
Of the $98 million in country grants approved by Global Fund Board from 2017-2019 allocations, Latin America and Caribbean receive $57 million
This is the second of two articles in this issue on the grants recently approved by the Global Fund Board. In this article, we report on the comments of the Grant Approvals Committee (GAC) on four countries in the Latin American and Caribbean region: Belize, El Salvador, Panama and Paraguay.
On 12 November 2018, through electronic voting, the Global Fund Board approved $98.0 million in funding for 14 country grants from 13 countries. Of the 14 grants, four were for TB; three TB/HIV; three HIV; three malaria; and one TB/RSSH.
Global Fund Board approves funding for first set of interventions on UQD register for 2017–2019 identified through portfolio optimization
On 17 August 2018 and on 26 October 2018, the Global Fund Board approved two HIV grants and three TB grants worth $28.1 million. The Board also approved $15.9 million in matching funds requests for six components.
Pakistan’s funding request to the Global Fund prioritizes TB case notification and treating MDR-TB cases
La demande de financement tuberculose/VIH du Cameroun auprès du Fonds mondial est axée sur les communautés et les populations clés
Cameroon’s 2017 TB/HIV funding request included a strong focus on communities and key populations. This was a key theme that emerged from the comments from the Technical Review Panel (TRP) and the Grant Approvals Committee (GAC) when they reviewed the request.